Skip to main content

Faculty Profile

Kevin GareyKevin W. Garey

Professor of Pharmacy Practice
Department Chair
Pharmacy Practice and Translational Research

Office: Health 2
University of Houston College of Pharmacy
4849 Calhoun, Room 4039
Houston, TX 77204-5039

Contact: - 832-842-8386


Dr. Garey's research interests are centered on clinical and translational research in healthcare associated infections including healthcare-related infections, candidemia, and Clostridium difficile infection.

  • Bachelor of Science in Pharmacy, 1991-95, Dalhousie University, Halifax, Nova Scotia
  • Doctorate of Pharmacy, 1995-97, University at Buffalo, Buffalo, NY
  • M.S. in Biometry, 2007, University of Texas School of Public Health, Houston, TX

Google Scholar Profile
  • KW Garey, M Rege, MP Pai, DE. Mingo, KJ Suda, RS Turpin, and DT Bearden. Time until initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study. Clin Infect Dis 2006;43 (1 July):25-31 PMID: 16758414
  • KW Garey, ZD Jiang, S Ghantoji, VH Tam, V Arora, and HL DuPont. A Common Polymorphism in the Interleukin-8 Gene Promoter is Associated with Increased Risk for Recurrent Clostridium difficile Infection. Clin Infect Dis 2010;51(12):1406-1410 PMID: 21058913
  • KW Garey, S Ghantoji, DN Shah, M Habib, V Arora, ZD Jiang, and HL DuPont. A randomized double-blind placebo-controlled pilot study to assess the effect of rifaximin to prevent recurrent diarrhea in patients with Clostridium difficile infection. J Antimicrob Chemother 2011;66(12):2850-5 PMID: 21948965
  • ND Beyda, J John, A Kilic, MJ Alam, TM Lasco, KW Garey. FKS mutant Candida glabrata; risk factors and outcomes in patients with candidemia. Clin Infect Dis 2014:15;59(6):819-25. PMID: 24879785
  • E Basseres, BT Endres, M Khaleduzzaman, F Miraftabi, MJ Alam, RJ Vickers, KW Garey. Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection. J Antimicrob Chemother 2016;71(5):1245-51. PMID: 26895772
  • BT Endres, E Bassères, M Khaleduzzan1, MJ Alam, L Chesnel, and KW Garey. Evaluating the Effects of Surotomycin Treatment on C. difficile Toxin A and B Production, Immune Response, and Morphologic Changes. Antimicrob Agents Chemother 2016 May 23;60(6):3519-23. PMID: 27021314
  • KW Garey, SL Aitken, L Gschwind, S Goddu, Y Xie, C Duff, F Barbut, DN Shah, and HL DuPont. Development and Validation of a Clostridium difficile Health-related Quality of Life Questionnaire. J Clin Gastro 2016 Sep;50(8):631-7. PMID 26796081
  • MJ Alam, ST Walk, BT Endres, E Basseres, M Khaleduzzaman, J Amadio, WL Musick, JL Christensen, J Kuo, RL Atmar, and KW Garey. Community environmental contamination of toxigenic Clostridium difficile. Open Forum Infect Dis 2017 Feb 10;4(1):ofx018. doi: 10.1093/ofid/ofx018. eCollection 2017 Winter PMID: 28480289
  • LC McDonald, DN Gerding, S Johnson, JS. Bakken, KC Carroll, SE Coffin, ER Dubberke, KW Garey, CV Gould, C Kelly, Loo, JS Sammons, TJ Sandora, MH Wilcox. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):987-94. PMID: 29462280
  • KR Reveles, KM Dotson, A Gonzales-Luna, D Surati, BT Endres, MJ Alam, KW Garey. Clostridioides (formerly Clostridium) difficile infection during hospitalization increases the likelihood of non-home patient discharge. Clin Infect Dis. 2019 May 17;68(11):1887-1893. PMID:30204878
  • TJ Carlson, BT Endres, JL Pham, AJ Gonzales-Luna, FS Alnezary, K Nebo, J Miranda, C Lancaster, E Bassères, K Begum, MJ Alam, KR Reveles, KW Garey. Eosinopenia and binary toxin increases mortality in hospitalized patients with Clostridioides difficile infection. Open Forum Infect Dis 2020 Jan 4;7(1):ofz552. doi: 10.1093/ofid/ofz552. PMID: 31993458;
  • AJ Gonzales-Luna, TJ Carlson, KM Dotson, K Poblete, G Costa, J Miranda, C Lancaster, S Walk, S Tupy, K Begum, MJ Alam, KW Garey. PCR ribotypes of Clostridioides difficile Across Texas from 2011-2018 including Emergence of Ribotype 255. Emerg Microbes Infect 2020; 9(1):341-347. PMID 32037964
  • Garey KW, Begum K, Lancaster C, Gonzales-Luna AJ; Bui D, Mercier J, Corinne, SY, Ducharme MP, Hu M, Vince B, Silverman MH, Alam MJ, Kankam M. Randomized, Double blind, Placebo controlled, Single and Multiple Ascending Dose Phase 1 Study to Determine the Safety, Pharmacokinetics, Food, and Fecal Microbiome Effects of Ibezapolstat Administered Orally to Healthy Subjects. J Antimicrob Chemother 2020 Sep 6:dkaa364. doi: 10.1093/jac/dkaa364. PMID: 32892222
  • AJ Gonzales-Luna, AO Olaitan, WJ Shen, A Deshpande, TJ Carlson, KM Dotson, C Lancaster, K Begum, MJ Alam, JG Hurdle, KW Garey. Reduced susceptibility to metronidazole is associated with initial clinical failure in Clostridioides difficile infection. Open Forum Infect Dis, 2021 July 8; ofab365. Doi: 10.1093/ofid/ofab365 PMID: 34381844
  • S Johnson, V Lavergne, AM Skinner, AJ Gonzales-Luna, KW Garey, CP Kelly, MH Wilcox. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults. Clin Infect Dis. 2021 Jun 24:ciab549. doi: 10.1093/cid/ciab549..PMID: 34164674

Awards & Honors

  • Research Fellowship Award, University of Illinois at Chicago 2000
  • SIDP Pharmacists Research Award. 2000
  • ACCP ID-PRN Resident/Fellow Research Award 2000
  • Rho Chi member 2003
  • Who's Who in Medicine and Healthcare 2003
  • University of Houston College of Pharmacy Rho Chi Teacher Excellence Award 2003
  • University of Houston College of Pharmacy Faculty Teaching Excellence Award 2003
  • Finalist, University of Houston Faculty Teaching Award 2004
  • University of Houston College of Pharmacy Rho Chi Teacher Excellence Award 2005
  • University of Houston College of Pharmacy Faculty Preceptor Award 2005
  • Selected Best Papers in Mycology ICAAC 2006, San Francisco, CA 2006
  • University of Houston College of Pharmacy Faculty Research Excellence Award 2007
  • SIDP Impact Paper in Infectious Diseases Pharmacotherapy Award 2007
  • ASHP Drug Therapy Research Award 2007
  • Best Review Paper of 2009, Journal of Hospital Infection 2009
  • ASHP Best Practices Award in Health-System Pharmacy 2010
  • Fellow, American Society of Health-System Pharmacy 2012
  • SIDP Impact Paper in Infectious Diseases Pharmacotherapy Award 2012
  • University of Houston PLS Faculty Leadership Award 2013
  • Top 10 Papers in Mycology, ICAAC 2014, Washington, DC 2014
  • Rho Chi Bergy Lecture Recipient, West Virginia University Morgantown, WV 2017
  • IDSA Antimicrobial Stewardship Center of Excellence, Baylor St. Luke’s Medical Center 2020